ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-1,198 Cr | ₹-1,068 Cr | ₹-942 Cr | ₹-955 Cr | ₹-643 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-1,198 Cr |
Mar2023 | ₹-1,068 Cr |
Mar2022 | ₹-942 Cr |
Mar2021 | ₹-955 Cr |
Mar2020 | ₹-643 Cr |
How is Deferred Tax Assets / Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,198 Cr | Negative | |
Mar2023 | ₹-1,068 Cr | Negative | |
Mar2022 | ₹-942 Cr | Negative | |
Mar2021 | ₹-955 Cr | Negative | |
Mar2020 | ₹-643 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹89,013.5 Cr | 0.5% | 5.6% | -10.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,588.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,711.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,115.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,589.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,746.6 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 0.5% |
5.6% |
-10.5% |
SENSEX | 2% |
9.4% |
11.6% |
You may also like the below Video Courses